HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO UISEE Technologies (PHIP Updates) - The Business, the Concerns and the Outlook

Pre-IPO Shanghai Top Numerical Control Technology (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Viewtrix Technology (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Chando Global Holding - Low Growth and Profitability Are Pain Points

Pre-IPO Tanboer Group - Low Profit Margin Is a Pain Poin

Pre-IPO Banu International Holding - The Pain Points and the Outlook

Pre-IPO Herb Standard Holdings Limited - The Business, the Concerns and the Outlook

Equity Capital Markets

SKG Health Technologies / Equity Capital Markets

<ul>
<li>Unlike mainstream manufacturers that build moats around operating systems, application ecosystems, and platform entry points, the product logic of future wearables is closer to that of medical device companies. </li>
<li>There is the tension between medical attributes and consumption efficiency. The real question is: Can this industry, which lies between healthcare and consumption, support the long-term expansion of SKG?</li>
<li>There's the tension between medical attributes and consumption efficiency. Given that SKG’s growth outlook is facing uncertainty but its profitability is solid, a P/E range of 15-25x is relatively reasonable.</li>
</ul>


Unlike mainstream manufacturers that build moats around operating systems, application ecosystems, and platform entry points, the product logic of future wearables is closer to that of medical device companies. 
There is the tension between medical attributes and consumption efficiency. The real question is: Can this industry, which lies between healthcare and consumption, support the long-term expansion of SKG?
There's the tension between medical attributes and consumption efficiency. Given that SKG’s growth outlook is facing uncertainty but its profitability is solid, a P/E range of 15-25x is relatively reasonable.


Pre-IPO SKG Health Technologies - The Industry, the Business and the Concerns